pital
Welcome to the 30th Annual Enterprise Awards.
Our region's most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology was held on May 23, 2023.
NAVIGATION
CELEBRATE OUR INNOVATORS!
LEGEND ENTERPRISE AWARD FOR LIFETIME ACHIEVEMENT


David J. Adelman
David J. Adelman is a Philadelphia-based entrepreneur and active private investor. As CEO of Philadelphia-based Campus Apartments, Adelman redefined the college living experience in University City and nationwide; today, he is widely recognized as a national leader in student housing development and management, with more than two billion dollars of assets under management across 18 states. Adelman is the Founder of Darco Capital which has made over 50 investments in venture capital and cofounder and vice chairman of FS Investments, a leading alternative asset manager with $34 billion of assets under management.
Adelman is also chairman of 76 Devcorp, responsible for conceptualizing and building a $1.3B privately funded urban arena in the heart of Philadelphia. He recently became a partner in Harris Blitzer Sports & Entertainment – which owns the 76ers, the NJ Devils and the Prudential Center.
Adelman serves on the Penn Medicine Board of Trustees, University City District Board of Directors, Chairman of the Jewish Federation of Greater Philadelphia, and past Chairman of Philadelphia Holocaust Remembrance Foundation where he spearheaded the development of The Horwitz-Wasserman Holocaust Memorial Plaza on the Ben Franklin Parkway.
Adelman was named one of Philadelphia’s Top Most Influential people by Philadelphia Magazine for two consecutive years, is a past recipient of the “Entrepreneur of the Year” award from Ernst & Young in the real estate category for Greater Philadelphia, and is a member of the Real Estate Roundtable. He received his BA in Political Science from Ohio State University and resides in the Philadelphia suburbs with his wife and two daughters.
FINALISTS
Life Sciences & Healthcare Startup
Interius BioTherapeutics
Verismo Therapeutics
Vittoria Biotherapeutics
Sponsor: Ben Franklin Technology Partners
Technology Startup
ImpactableX
Lula Convenience
WhipFlip
Sponsors: Bank of America and Troutman Pepper
Investment Deal
Biocoat
Center for Breakthrough Medicines
Sidecar / Quartile
Sponsor: Baker Tilly
Life Sciences & Healthcare Emerging
AnaOno
Biomeme
StationMD
Sponsor: RSM
Technology Emerging
Exyn Technologies
LoanStar Technologies
Malbek
Sponsors: Broadpath and Fox Rothschild
Life Sciences & Healthcare CEO
Tom Anderson, SwanBio Therapeutics
Hervé Hoppenot, Incyte
Melissa Sherman, MOBILion Systems
Sponsors: EY and Morgan Lewis & Bockius
Technology CEO
Mike Lahiff, ZeroEyes
Christopher Molaro, NeuroFlow
Jagath Wanninayake, Suvoda
Sponsor: Cozen O’Connor
Healthcare Innovator
Avisi Technologies
Code Bio
Kibow Therapeutics
Sponsor: Independence Blue Cross
Life Sciences & Healthcare Company
AscellaHealth
Century Therapeutics
Spark Therapeutics
Sponsor: Blank Rome
Technology Company
Clinical ink
Infinite Blue
YPrime
Sponsor: Comcast Business
Sponsors
Title Sponsor


Judging Partner


AWARD SPONSORS
EVENT SPONSORS
EVENT SPONSORS
Judges
LEAD JUDGE
Rick Riegel
Chairman
ActiGraph and Deerfield
Technology Judging Panel Oversight
Andrew Cherry
Partner
KPMG
Life Sciences & Healthcare Judging Panel Oversight
Jennifer Strong
Partner
KPMG
Tom Koncsics
Partner
KPMG
LEAD JUDGE
Rick Riegel
Chairman
ActiGraph and Deerfield
Technology Judges
Mike Bachman
Global Architect & Principal Technologist
Boomi
Joseph Biancaniello
VP, Commercial and Technology Banking
JP Morgan
Sean Dowling
Partner
Osage Partners
Brad Goldoor
Co-Founder
Phenom People
Janet Harrison
Division Director, Information Systems
AMETEK
David Henkin
Chief Innovation Officer
Vertex Inc.
Andrew Kress
CEO
HealthVerity
Bharat Santhanam
Vice President
NewSpring Capital
Life Sciences & Healthcare Judges
Tom Anderson
CEO
SwanBio
Victor Caraballo
Vice President Quality Management
Independence Blue Cross
Gerianne DiPiano
Chief Executive Officer
FemmePharma
Maneesh Goel
SVP, Senior Relationship Manager
Bank of America
Audrey Greenberg
Co-Founder & Chief Business Officer
Center for Breakthrough Medicines
Matthew Reber
Partner
1315 Capital
Heather Steinman
VP Business Development and Executive Director of Technology Transfer
The Wistar Institute
Zev Sunleaf
Vice President
Office of Technology Transfer, Commercialization & Innovation
Children’s Hospital of Philadelphia
Award Criteria
To view the Enterprise Awards applications, please click on each award heading below.
The deadline for nominations was Friday, November 18th.
HEALTHCARE INNOVATOR
Sponsor: Independence Blue Cross
Criteria:
- The nominee can be a company, researcher, or investor providing an innovative solution that has the potential to make a large and positive impact on cost, quality, and/or access in health care.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- The Nominee must demonstrate creativity and passion to re-thinking healthcare in the region and to driving exceptional health outcomes or dramatically lowering costs.
- The nominee should have a demonstrated business model for its solution and demonstrate the ability to generate rapid growth or adoption.
- The Nominee can be in any sector (technology, life sciences, investment, healthcare delivery., etc.), but must be serving the healthcare industry in Greater Philadelphia.
INVESTMENT DEAL
Sponsor: Baker Tilly
Criteria:
- Deal must have been fully executed between November 1, 2021, and October 31, 2022.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
- Events that qualify for this category include: IPO, Capital Raise, Buy-side or Sell-side of a Merger & Acquisition Transaction.
Key Considerations:
- Realized returns for the investors and management.
- EBITDA margin and revenue growth.
- Strategic considerations of the deal (e.g. commercial strategy, innovation, and contribution to market development.
- Company performance prior to transaction.
- How the sale or purchase impacted the broader industry(s) of the buyer and/or seller.
LIFE SCIENCES & HEALTHCARE STARTUP
Sponsors: Blank Rome and Ben Franklin Technology Partners
Criteria:
- Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point between January 1, 2019, and December 31, 2022.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Product innovation including unmet market need and how that is uniquely addressed by your product/service.
- The management team and its ability and record of achieving success.
- Provide demonstration of success (e.g., significant milestones, raising capital, revenue, etc.).
- Describe the R&D investment strategy.
- What did the company do to overcome challenges in financing, development, or commercialization?
LIFE SCIENCES & HEALTHCARE EMERGING
Sponsors: SAP and RSM
Criteria:
- Company must have been in operation beginning on January 1, 2019. The Company should have no more than 8 years of operating results since its founding.
- Must have sales, grants, or licensing fees.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Describe product or service, including proprietary applications or other competitive advantage.
- The impact on the clinical problem this product or innovation is trying to solve (e.g. saving a hospital money on a procedure, making a clinician more productive, etc.).
- Company milestones including strategic decisions made by the management team that led to growth in revenues and/or earnings, corporate collaborations, or license deals (e.g. ability to raise capital, strategy to achieve breakeven, ability to realize high gross margins, etc.).
LIFE SCIENCES & HEALTHCARE COMPANY OF THE YEAR
Criteria:
- Company must have at least four years of operating results in industry segments such as specialty pharmaceuticals, biotechnology, medical devices, instrumentation, therapeutics, diagnostics, health tech, etc.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Company should demonstrate the impact of a proprietary product to the patient and/or clinician or research and development of an innovative product and its potential impact on the market.
- Company should demonstrate its ability to raise capital; achieve success in its development strategy and clinical pathway; commercialize and generate revenue.
- Describe any significant events, e.g. product discovery, drug registration, commercial launch, an exit, an increase in sales, etc. that occurred in 2022.
- What did the company do to overcome challenges in financing, development, or commercialization?
LIFE SCIENCES & HEALTHCARE CEO
Sponsors: EY and Morgan Lewis
Criteria:
- CEO must be in his/her position for at least two years.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the Company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talented resources.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community/industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the life sciences/healthcare industry in the region.
TECHNOLOGY CEO
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsor: Cozen O’Connor
Criteria:
- Individual’s background (CV/Bio required) and the company’s success to date.
- The CEO must be in his/her position for at least two years.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- CEO’s management accomplishments and philosophy, including the communication of a vision and goals as achieved by the company.
- Leadership and impact in industry and/or market.
- Ability to attract and retain talented resources.
- Company milestones including financial accomplishments and a strategy for continued company success.
- Community and/or industry involvement.
- Extra consideration is given to leaders who have contributed more broadly to the strengthening and promotion of the technology industry in the region.
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsor: Comcast Business
Criteria:
- Company with more than $50 million in revenues projected for the current fiscal year.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Leadership and product and/or service innovation in an industry or market.
- Significant company milestones including financial accomplishments.
- The Company’s connection and commitments to the Greater Philadelphia region through community and industry involvement.
TECHNOLOGY STARTUP
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsors: Troutman Pepper and Bank of America
Criteria:
- Company should have been founded, launched meaningful operations, or pivoted to current strategic focus at some point in the period between January 1, 2019, and December 31, 2022.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Product or service innovation including market need or assessment.
- Potential for significant growth.
- The management team and its ability and record of achieving success.
- A demonstration of success such as significant milestones, raising capital, and revenue.
TECHNOLOGY EMERGING
A technology company must either provide proprietary technology or intellectual property or services that leverage proprietary technology or IP.
Sponsors: Fox Rothschild and Broadpath
Criteria:
- Company must have been in operation before January 1, 2019.
- Revenues must be less than $50 million. *If revenues are projected to exceed $50m in 2022, please complete the Technology Company application.
- Company must have its HQ or significant operations in the region and a significant portion of its leadership, employees, and consultants must be based in the region.
Key Considerations:
- Product or service innovation, including proprietary technology or other advantage.
- Company milestones including strategic decisions made by management that led to growth in revenues and/or earnings.
- Strength of management team including ability to raise capital.
- Demonstration of a sustainable and scalable business model